Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases, and its development involves multiple mechanisms. Gut microbiota has been reported to be closely linked to hypertension. Short-chain fatty acids (SCFAs)—the metabolites of gut microbiota—participate in hypertension development through various pathways, including specific receptors, immune system, autonomic nervous system, metabolic regulation and gene transcription. This article reviews the possible mechanisms of SCFAs in regulating blood pressure and the prospects of SCFAs as a target to prevent and treat hypertension
Emerging data indicate a correlation between gut microbial composition and cardiovascular disease in...
Increasing experimental and clinical evidence points toward a very important role for the gut microb...
Due to changes in lifestyle, diet structure, and aging worldwide, the incidence of metabolic syndrom...
Cardiac disorders contribute to one of the major causes of fatality across the world. Hypertensive p...
Arterial hypertension is a chronic disease which is very prevalent contemporarily. The aim of this r...
Recent evidence suggests that the gut microbiota plays an important role in the development and path...
Gut microbiota and its metabolites such as short chain fatty acids (SCFA), lipopolysaccharides (LPS)...
Arterial hypertension and its organ sequelae show characteristics of T cell–mediated inflammatory di...
Elevated sympathetic outflow is an important contributor to the salt-sensitive hypertension (SSH). I...
Over the past decade, the immune system has emerged as an important component in the aetiology of hy...
The maintenance of the physiological values of blood pressure is closely related to unchangeable fac...
The gut microbiota plays an important role in cardio-metabolic diseases with diet being among the st...
The pathogenesis of hypertension is known to involve a diverse range of contributing factors includi...
While hypertension remains the leading modifiable risk factor for cardiovascular morbidity and morta...
Intestinal microbiota has its role as an important component of human physiology. It produces metabo...
Emerging data indicate a correlation between gut microbial composition and cardiovascular disease in...
Increasing experimental and clinical evidence points toward a very important role for the gut microb...
Due to changes in lifestyle, diet structure, and aging worldwide, the incidence of metabolic syndrom...
Cardiac disorders contribute to one of the major causes of fatality across the world. Hypertensive p...
Arterial hypertension is a chronic disease which is very prevalent contemporarily. The aim of this r...
Recent evidence suggests that the gut microbiota plays an important role in the development and path...
Gut microbiota and its metabolites such as short chain fatty acids (SCFA), lipopolysaccharides (LPS)...
Arterial hypertension and its organ sequelae show characteristics of T cell–mediated inflammatory di...
Elevated sympathetic outflow is an important contributor to the salt-sensitive hypertension (SSH). I...
Over the past decade, the immune system has emerged as an important component in the aetiology of hy...
The maintenance of the physiological values of blood pressure is closely related to unchangeable fac...
The gut microbiota plays an important role in cardio-metabolic diseases with diet being among the st...
The pathogenesis of hypertension is known to involve a diverse range of contributing factors includi...
While hypertension remains the leading modifiable risk factor for cardiovascular morbidity and morta...
Intestinal microbiota has its role as an important component of human physiology. It produces metabo...
Emerging data indicate a correlation between gut microbial composition and cardiovascular disease in...
Increasing experimental and clinical evidence points toward a very important role for the gut microb...
Due to changes in lifestyle, diet structure, and aging worldwide, the incidence of metabolic syndrom...